BackVaxxinity Overview

Vaxxinity Total Liabilities

Latest total liabilities for VAXX: $31M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$30.94M
↓ 30.03% YoYΔ $-13.28M vs prior year quarter

Peer average

Loading

Vaxxinity Total Liabilities History

Loading

Vaxxinity vs. peers: Total Liabilities Comparison

Loading

Vaxxinity Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vaxxinity (VAXX) FAQ

As of the most recent data (December 2023), VAXX shows a total liabilities of $31M. That compares with $44M in the prior-year period — down 30.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VAXX's total liabilities is now $31M (was $44M) — a 30.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vaxxinity is outperforming or lagging.

Tracking VAXX's total liabilities over time shows whether Vaxxinity is scaling, shrinking, or reshaping that part of the business. The current reading is $31M That compares with $44M in the prior-year period — down 30.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Vaxxinity's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $31M) with ownership activity and broader fundamentals.